PyInvesting

Market research

CHE Chemed Corp

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
7B
P/E ratio
27.18
Analyst target
552
Dividend yield
0.4%
Beta
0.51

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Chemed Corporation is currently in a long term downtrend where the price is trading 2.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.

Chemed Corporation's total revenue rose by 2.1% to $533M since the same quarter in the previous year.

Its net income has increased by 73.5% to $114M since the same quarter in the previous year.

Finally, its free cash flow grew by 40.5% to $71M since the same quarter in the previous year.

Based on the above factors, Chemed Corporation gets an overall score of 4/5.